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1. Introduction 
In [1-3] binding to muscarinic receptors was 
performed on homogenate of whole mouse brain 
using the potent and highly specific antagonist 
N-[3H] methyl-4-piperidylbenzilate ([3HI -4NMPB). 
The non-linearity of Scatchard plots found in equi- 
librium studies, and the demonstration f biphasic 
kinetics, led to the formulation of the following 
scheme: 
R + L ~ RL 
R* + L ~ RL* 
This formulation was the simplest one that could 
accomodate he assumption of homogeneity of the 
receptors in the preparation. However, this cyclic 
scheme includes an irreversible step which contra- 
dicts the requirement of microscopic reversibility. 
This prompted us to question the assumption of 
receptor homogeneity in the mouse brain. 
2. Materials and methods 
Labelled and non-labelled compounds are the 
same as in [1-3].  Direct binding studies, competi- 
tion experiments and the analysis of binding kinetics 
were carried out as detailed in [1-3]. Choline acetyl- 
transferase and cholinesterase activities were deter- 
mined according to [4,5]. 
Male 1CR mice (20-25 g) were decapitated, brains 
were rapidly removed and the brain areas were dis- 
sected in a cold room after identification with the aid 
of [6]. After dissection, brain regions (from 15-25 
mice for the thalamus and 10-15 mice for other 
regions) were homogenized in ice-cold 0.32 M sucrose 
using a motor-driven Teflon pestle (950 rev./min) in a 
glass homogenizer to yield a 10% homogenate (w/v). 
Specific binding is defined as the total minus the 
non-specific, i.e., binding in the presence of 5 X 10-s M 
of unlabelled ligand. 
3. Results and discussion 
The binding of [3H]-4NMPB at 25°C was studied 
as in [ 1-3 ] in homogenates of the following brain 
regions: cortex, caudate putamen, hippocampus 
thalamus, medulla pons and cerebellum. The density 
of [3H]-4NMPB binding sites together with the 
activities of choline acetyl-transferase nd of cholin- 
esterase found in the various regions are given in 
table 1. In agreement with neurophysiological studies 
[7,8 ], we found variations in the 4NMPB binding site s 
with at least a 13-fold variation between the putamen, 
containing the highest density of binding sites, and 
the cerebellum, the lowest. This distribution is in 
agreement with known distributions of muscarinic 
receptors in other mammalian brains. The other 
cholinergic markers tudied here, closely parallel 
each other in the various regions (for comparison see 
also [8]) and correlate well with the 4NMPB binding 
in the same areas (table 1). However, as shown there 
are some discrepancies in these correlations. Thus, 
e.g., the CAT activity appears to be high within the 
medulla pons while its 4NMPB binding is relatively 
low as also was demonstrated in monkey brain [8]. 
Interpretation atthis stage must be made cautiously 
since the transmitter synthesis takes place both in cell 
bodies and nerve terminals while receptor binding 
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Table 1 
Regional distribution of specific [3H ]-4NMPB binding, choline acetyRransferase 
(CAT) and cholinesterase (ChE) activities in mouse brain regions 
Region [ 3H]-4NMPB a ChE b (nmol CAT b (nmol AcCh 
binding AcCh hydrolyzed] synthesized• 
(pmol/protein) mg protein/min) mg protein/h) 
Caudate 
putamen 1.54 ± 0.38 457 -+ 60 23.0 ± 6 
Hippocampus 1.05 ± 0.05 107 ± 10 10.1 ± 2 
Cortex 0.91 ± 0.06 61 ± 6 8.0 ± 3 
Thalamus 0.61 ± 0.10 98 -+ 7 11.6 + 3 
Medulla 
pons 0.26 ± 0.05 65 ± 5 34.1 ± 5 
Cerebellum 0.12 -+ 0.01 12 ± 3 2.0 ± 1 
a The values given are the mean of at least 4 separate binding curves ± SEM 
b The values given are the mean ± SEM of 6 samples 
presumably islargely associated with the post-synaptic 
membrane. 
Equil ibrium binding studies of  [3H]-4NMPB were 
performed with the homogenates of  the cortex, 
thalamus and medulla pons, at 0 .25-20  nM. Specific 
ligand binding exhibits the hyperbol ic shape curve 
typical for saturation phenomena. Non-specific 
binding is much lower and varies linearly with ligand 
concentration. The binding data, when replotted 
according to Scatchard, gave straight lines for each of  
the regions examined indicating a single populat ion of  
binding sites within each region at the concentrat ion 
range investigated. The binding constants measured in 
these experiments are given in table 2. 
The nature of  the high affinity binding of  
[3H]-4NMPB to the 3 regions was examined by com- 
petit ion experiments in which selected unlabelled 
muscarinic ligands inhibit the binding of  [ 3H]-4NMPB. 
Table 2 
Binding parameters for muscarinic antagonists and agonists determined by direct 
binding and competition with 2 nM [~H]-4NMPB 
Ligand Binding Cortex Thalamus Medulla pons 
parameter 
3H-4NMPB K d (nM) 0.4 ± 0.03 0.5 ± 0.06 0.82 ± 0.09 
Scopolamine K d (nM) 0.62 -+ 0.07 2.0 ± 0.15 2.6 ± 0.30 
Carbamylcholine /so (taM) 170 ± 20 3.0 -+ 0.23 4.7 ± 0.61 
Arecoline Is0 (taM) 55 -+ 6 9.1 ± 1.27 4.2 +- 0.54 
Acetyleholine /so (uM) 30 +- 4 1.8 ± 0.25 3.0 +- 0A0 
Values for K d for agonists depend on their mode of binding and hence values of 
lso are given; i.e., the concentration of drug causing 50% reduction in binding of 
[ 3H]-4NMPB under the experimental conditions described. Values for K d for 
antagonists were calculated as in [ 1,2], assuming asimple competitive interaction 
between 4NMPB and the competing ligand. The average values of Iso and binding 
constants determined, are the means -+ SEM of 3-4  separate xperiments, each 
performed in triplicate. For cholinesterase-sensitive agonists the assay contained 
10-s M physostigmine. This concentration of inhibitor did not affect the binding 
characteristics of [3H]-4NMPB in the absence of agonists 
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Fig.1. Left: Initial rate of [~H]-4NMPB binding at different ligand concentrations to thalamus preparation. Homogenates (0.05 ml) 
were incubated with 0.5 nM (o), 2.5 nM (o) and 5.0 nM (•), [3H]-4NMPB at 25°C in 2 ml modified Krebs solution for the various 
time intervals. Association was begun by addition of tissue (88 pM binding sites), terminated by rapid filtration, and specific 
binding was determined as in section 2. Each experimental point is the mean of triplicate samples whose standard error was < 5%. 
The data are plotted according to the equation: 
In (Beq-  Bt) =(k  I [4NMPB]+k_1 ) . t  
Beq 
where Beq and B t are the concentrations of the bound ligand at equilibrium and at time t. 
Fig. 1. Right: Dissociation of [3H]-4NMPB from the muscarinie receptors in the thalamus preparation. Samples (0.05 ml) were 
incubated to equilibrium at 25°C in the presence of 5 nM [3H]-4NMPB. Dissociation was begun by addition of 50 tzM 4-NMPB to 
tubes and the samples were filtered immediately (zero time) and at the times indicated. Specific binding was determined as in the 
text. Each point is the mean of at least 3 experiments whose standard error was < 5%. ([3H]-4NMPBbound)t= 0 was 0.57 pmol/mg 
protein. 
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The binding constants and/so values measured in 
these competition experiments are given in table 2. 
The data demonstrates some small but nonetheless 
reproducible differences between the K d values of  
antagonists binding to the various regions, with lowest 
affinity at the medulla pons. On the other hand the 
Iso values for agonists reveal an opposite and more 
pronounced ifferences: compare the values of the 
medulla and thalamus with that of the cortex. 
Binding was investigated further kinetically. 
Figure 1 (left) shows the initial rate of  [aH]-4NMPB 
binding to the thalamus homogenate at different 
ligand concentrations. Under such pseudo first order 
conditions the data should yield straight lines if the 
reaction is bimolecular. However, fig.1 demonstrates 
biphasic behavior. Similar biphasic behavior was 
observed for the binding of [all] 4NMPB to 
homogenates of the other two regions. The calculated 
Kon X 108 (M -1 min -1) are 4.03 for the medulla, 
4.5 for the thalamus and 2.45 for the cortex. 
An isotopic dilution technique is suitable to follow 
the course of dissociation of l igand-receptor complex. 
Figure 1 (right hand) demonstrates the first order 
plot for the dissociation of [aH]-4NMPB from the 
thalamus preparation. The first order plot deviates 
from linearity. Similar biphasic behavior was observed 
for the dissociation from the other regions studied. 
The apparent half-life times of the dissociation of 
[3H]-4NMPB from binding sites in the medulla pons, 
thalamus and cortex are 5 min, 5 min and 20 min, 
respectively. It is noteworthy that the trend in the 
kinetics experiments i  consistent with the differences 
in K d as discussed (vide supra). Thus, the weight of 
the evidence rests with a regional heterogeneity of
muscarinic receptors in mouse brain. Therefore the 
irreversible cyclic scheme which assumes homogeneity 
is indeed inadequate. Two different schemes are more 
consistent with the kinetics experimental results. The 
first one is linear, i.e., R + L g RL ~ R*L. The second 
one is again a cyclic scheme but it includes reversible 
reactions for all the steps: 
R + L +-+ RL 
f$ 1'$ 
R* + L ~ R*L 
Note that the transformation of R-+R* is much 
slower than the reverse reaction, therefore the reac- 
tion might be practically irreversible. Presently we 
are engaged in chase experiments with the purpose 
of establishing the forward and back rates of R*-+R. 
This will allow us to distinguish between the two 
schemes presented here. Ligand-induced isomeriza- 
tion of the muscarinic receptors proposed [1-3]  has 
now been reported independently for the chick heart 
[9], retina and neuroblastoma [10]. Recent charac- 
terizations of these receptors in the irides of rabbit 
[11] and cat [12] yielded similar results, thus 
increasing the variety of systems in which an iso- 
merization step appears to be related to the interaction 
of  antagonists with muscarinic receptors. 
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